Cite
HARVARD Citation
Aggarwal, N. et al. (2022). Real-World Evidence of the Neutralizing Monoclonal Antibody Sotrovimab for Preventing Hospitalization and Mortality in COVID-19 Outpatients. Journal of infectious diseases. pp. 2129-2136. [Online].